Haemonetics Corp (HAE)
85.43
+0.51
(+0.60%)
USD |
NYSE |
Nov 21, 16:00
85.46
+0.04
(+0.04%)
Pre-Market: 20:00
Haemonetics Shareholders Equity (Quarterly): 878.85M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 878.85M |
June 30, 2024 | 905.37M |
March 31, 2024 | 959.96M |
December 31, 2023 | 943.32M |
September 30, 2023 | 893.66M |
June 30, 2023 | 864.62M |
March 31, 2023 | 818.00M |
December 31, 2022 | 775.98M |
September 30, 2022 | 729.01M |
June 30, 2022 | 770.42M |
March 31, 2022 | 749.42M |
December 31, 2021 | 730.78M |
September 30, 2021 | 698.55M |
June 30, 2021 | 677.08M |
March 31, 2021 | 731.67M |
December 31, 2020 | 719.15M |
September 30, 2020 | 667.92M |
June 30, 2020 | 608.57M |
March 31, 2020 | 587.11M |
December 31, 2019 | 574.58M |
September 30, 2019 | 583.75M |
June 30, 2019 | 590.97M |
March 31, 2019 | 667.87M |
December 31, 2018 | 643.13M |
September 30, 2018 | 701.34M |
Date | Value |
---|---|
June 30, 2018 | 674.06M |
March 31, 2018 | 752.43M |
December 31, 2017 | 822.81M |
September 30, 2017 | 801.25M |
June 30, 2017 | 772.77M |
March 31, 2017 | 739.61M |
December 31, 2016 | 770.90M |
September 30, 2016 | 749.11M |
June 30, 2016 | 715.56M |
March 31, 2016 | 721.56M |
December 31, 2015 | 719.55M |
September 30, 2015 | 776.88M |
June 30, 2015 | 791.65M |
March 31, 2015 | 826.12M |
December 31, 2014 | 833.91M |
September 30, 2014 | 820.72M |
June 30, 2014 | 815.07M |
March 31, 2014 | 837.89M |
December 31, 2013 | 825.22M |
September 30, 2013 | 796.47M |
June 30, 2013 | 774.38M |
March 31, 2013 | 769.18M |
December 31, 2012 | 779.16M |
September 30, 2012 | 771.97M |
June 30, 2012 | 757.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
574.58M
Minimum
Dec 2019
959.96M
Maximum
Mar 2024
764.20M
Average
740.55M
Median
Shareholders Equity (Quarterly) Benchmarks
Boston Scientific Corp | 20.71B |
Baxter International Inc | 7.872B |
Globus Medical Inc | 4.069B |
ResMed Inc | 5.195B |
Integra Lifesciences Holdings Corp | 1.522B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.525B |
Total Liabilities (Quarterly) | 1.646B |
Debt to Equity Ratio | 1.394 |
Current Ratio | 3.489 |
Net Debt Paydown Yield | -2.27% |